Collectively, our findings show that genetic and pharmacological inhibition of NOX2 abrogates ion channel and structural remodeling in both Nox2-KO mice and mature hiPSC-aCMs and prevents the development of obesity-mediated AF by modulating PITX2 expression. This evidence concerns the gene CYBB and atrial fibrillation.